NCT03584204 Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
| NCT ID | NCT03584204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bonn |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2018-01-01 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.
Eligibility Criteria
Inclusion Criteria: * liver cirrhosis of any etiology * CT scan available Exclusion Criteria: * HCC or any malignant disease
Contact & Investigator
Michael Praktiknjo, MD
PRINCIPAL INVESTIGATOR
University Hospital, Bonn
Frequently Asked Questions
Who can join the NCT03584204 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03584204 currently recruiting?
Yes, NCT03584204 is actively recruiting participants. Contact the research team at michael.praktiknjo@ukbonn.de for enrollment information.
Where is the NCT03584204 trial being conducted?
This trial is being conducted at Bonn, Germany, Frankfurt, Germany, Roma, Italy.
Who is sponsoring the NCT03584204 clinical trial?
NCT03584204 is sponsored by University Hospital, Bonn. The principal investigator is Michael Praktiknjo, MD at University Hospital, Bonn. The trial plans to enroll 400 participants.